3rd FDA Panelist Resigns Over Approval of Alzheimer’s Drug

Another member of the Food and Drug Administration’s advisory panel resigned and called this week’s approval of an Alzheimer’s drug “probably the worst drug approval decision in recent U.S. history.” Harvard’s Aaron Kesselheim made the claim as the third expert advisory…